Cargando…
Cystatin C-Properties and use as diagnostic marker
This chapter focuses on the most well characterized inhibitors—cystatin C—and provide some information on its structure, biochemical properties, its role in normal and abnormal physiological processes, as well as on its use as a diagnostic marker. A major part of the cysteine proteases are evolution...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130541/ https://www.ncbi.nlm.nih.gov/pubmed/11040958 http://dx.doi.org/10.1016/S0065-2423(01)35015-1 |
_version_ | 1783517033730670592 |
---|---|
author | Grubb, Anders O. |
author_facet | Grubb, Anders O. |
author_sort | Grubb, Anders O. |
collection | PubMed |
description | This chapter focuses on the most well characterized inhibitors—cystatin C—and provide some information on its structure, biochemical properties, its role in normal and abnormal physiological processes, as well as on its use as a diagnostic marker. A major part of the cysteine proteases are evolutionary related to the structurally well–defined cysteine protease papain and are called papain–like cysteine proteases. The biological roles and the cystatin superfamily inhibitors of papain–like cystein proteases are also discussed. The aminoacid sequence and schematic structure of human cystatin C is also presented. The evolutionary relationships among all known inhibitory active human cystatins and kininogen cystatin domains are diagrammatically represented. The distribution of cystatins in body fluids and additional functions attributed to cystatin C are described. The serum or plasma cystatin C is used as a marker for glomerular filtration rate (GFR). The urine cystatin C is used as a marker for proximal tubular damage. The two types of brain hemorrhage associated with Cystatin C amyloid deposits are also demonstrated. The conditions connected with deposition of amyloid β–protein in cystatin C and cerebral hemorrhage is also provided. |
format | Online Article Text |
id | pubmed-7130541 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71305412020-04-08 Cystatin C-Properties and use as diagnostic marker Grubb, Anders O. Adv Clin Chem Article This chapter focuses on the most well characterized inhibitors—cystatin C—and provide some information on its structure, biochemical properties, its role in normal and abnormal physiological processes, as well as on its use as a diagnostic marker. A major part of the cysteine proteases are evolutionary related to the structurally well–defined cysteine protease papain and are called papain–like cysteine proteases. The biological roles and the cystatin superfamily inhibitors of papain–like cystein proteases are also discussed. The aminoacid sequence and schematic structure of human cystatin C is also presented. The evolutionary relationships among all known inhibitory active human cystatins and kininogen cystatin domains are diagrammatically represented. The distribution of cystatins in body fluids and additional functions attributed to cystatin C are described. The serum or plasma cystatin C is used as a marker for glomerular filtration rate (GFR). The urine cystatin C is used as a marker for proximal tubular damage. The two types of brain hemorrhage associated with Cystatin C amyloid deposits are also demonstrated. The conditions connected with deposition of amyloid β–protein in cystatin C and cerebral hemorrhage is also provided. Published by Elsevier Ltd. 2001 2006-11-06 /pmc/articles/PMC7130541/ /pubmed/11040958 http://dx.doi.org/10.1016/S0065-2423(01)35015-1 Text en Copyright © 2001 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Grubb, Anders O. Cystatin C-Properties and use as diagnostic marker |
title | Cystatin C-Properties and use as diagnostic marker |
title_full | Cystatin C-Properties and use as diagnostic marker |
title_fullStr | Cystatin C-Properties and use as diagnostic marker |
title_full_unstemmed | Cystatin C-Properties and use as diagnostic marker |
title_short | Cystatin C-Properties and use as diagnostic marker |
title_sort | cystatin c-properties and use as diagnostic marker |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130541/ https://www.ncbi.nlm.nih.gov/pubmed/11040958 http://dx.doi.org/10.1016/S0065-2423(01)35015-1 |
work_keys_str_mv | AT grubbanderso cystatincpropertiesanduseasdiagnosticmarker |